Acorda Therapeutics Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Acorda Therapeutics Inc.

ACOR 0.880

-13.8%

Apr 10 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (36)	8/4/2009 2:43:53 PM
From: kenhott	1 Recommendation Read Replies (2) of 120

From the CC, these "relapses" are a mix bag of different things that the docs ID'd as AEs and called it something like "relapse". Docs know what MS exacerbations look like. So if someone is having MS like issues with their eyes or their arm, etc., and it doesn't really fit common AE categories like fatigue or headaches, etc., the docs may call it MS relapse. I don't think this is a pure count of cases of MRI lesions which could mean something serious. So if a drug improves communication between the MS brain and the MS body, and the drug is stopped, I would expect some of the patient's body to have MS like exacerbations. I know I am probably just repeating myself.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next